| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/04/2011 | US8030468 Human T2R51 taste receptor nucleic acid sequences and polypeptides |
| 10/04/2011 | US8030466 3′-o-fluorescently modified nucleotides and uses thereof |
| 10/04/2011 | US8030463 Method for detecting and quantifying endogenous wheat DNA sequence |
| 10/04/2011 | US8030460 Compounds and methods for labeling oligonucleotides |
| 10/04/2011 | US8030451 Isolated bitter taste receptor polypeptides |
| 10/04/2011 | US8030280 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 10/04/2011 | US8030275 Methods for treating obesity using fibroblast growth factor-like polypeptides |
| 10/04/2011 | US8030096 Water-soluble rhodamine dyes conjugates |
| 10/04/2011 | US8030092 Sequentially analyzing a single or multiple samples having one or more analytes in a wide range of concentrations; |
| 10/04/2011 | US8030089 Method of analyzing differential expression of proteins in proteomes by mass spectrometry |
| 10/04/2011 | US8030084 Thyroglobulin quantitation by mass spectrometry |
| 10/04/2011 | US8030081 Reagent for quantitative determination of small, dense LDLs |
| 10/04/2011 | US8030074 In vivo incorporation of unnatural amino acids |
| 10/04/2011 | US8030069 Conductive polymer matrix and device for use in the efficient isolation of preferential stem cells; permits the monitoring of cell binding to the solid matrix during the selection process, it is possible to obtain feedback information on the number of selected cells at any time |
| 10/04/2011 | US8030067 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 10/04/2011 | US8030060 Gene signature for diagnosis and prognosis of breast cancer and ovarian cancer |
| 10/04/2011 | US8030059 Apparatus for measuring extracellular potential |
| 10/04/2011 | US8030044 Lipid acyltransferases |
| 10/04/2011 | US8030036 Method for producing L-lysine or L-threonine |
| 10/04/2011 | US8030033 Polymorphisms in ABCB1 associated with a lack of clinical response to medicaments |
| 10/04/2011 | US8030031 Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer |
| 10/04/2011 | US8030018 Method for measuring enzymatic activity in vivo by use of laser |
| 10/04/2011 | US8030017 Thermostable luciferases and methods of production |
| 10/04/2011 | US8030013 Methods and compositions for the diagnosis for early hepatocellular carcinoma |
| 10/04/2011 | US8030012 Id-1 and Id-2 genes and products as markers of epithelial cancer |
| 10/04/2011 | US8030009 Human T2R67 taste receptor and related assays for identifying human bitter taste modulators |
| 10/04/2011 | US8030004 Cell free screening assay and methods of use |
| 10/04/2011 | US8030002 Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions |
| 10/04/2011 | US8030001 detecting a nucleic acid of Candida albicans which is a pathogenic fungus with a high degree of accuracy even for an analyte containing DNAs of a plurality of fungi with a less cross-contamination level |
| 10/04/2011 | US8030000 Recombinase polymerase amplification |
| 10/04/2011 | US8029999 Complexity management of genomic DNA |
| 10/04/2011 | US8029998 Genetic markers for prognosis of antifolate treatment efficacy |
| 10/04/2011 | US8029997 Methods of analysis of allelic imbalance |
| 10/04/2011 | US8029996 Method for the determination of cystosine methylation in CpG islands |
| 10/04/2011 | US8029995 Gene expression markers for colorectal cancer prognosis |
| 10/04/2011 | US8029994 Method of identifying a target analyte using photonic crystal resonators, and related device |
| 10/04/2011 | US8029993 Asymmetric adapter library construction |
| 10/04/2011 | US8029992 Methods of evaluating cells and cell cultures |
| 10/04/2011 | US8029991 Method and formulation for the extraction of nucleic acids from any complex starting materials |
| 10/04/2011 | US8029990 Cell transfection array for introduction of nucleic acid |
| 10/04/2011 | US8029989 Method using snail transcriptional repressor |
| 10/04/2011 | US8029988 Oligonucleotide mediated nucleic acid recombination |
| 10/04/2011 | US8029987 Method for detecting C. albicans |
| 10/04/2011 | US8029986 KASPP (LRRK2) gene, its production and use for the detection and treatment of neurodegenerative disorders |
| 10/04/2011 | US8029985 Amplified bioassay |
| 10/04/2011 | US8029984 Materials and methods for colorectal cancer screening, diagnosis and therapy |
| 10/04/2011 | US8029982 Biomarkers for sepsis |
| 10/04/2011 | US8029981 Hypoxia-inducible protein 2 (HIG2), a diagnostic marker for clear cell renal cell carcinoma |
| 10/04/2011 | US8029980 Using tumor necrosis factor superfamily of ligands as therapeutic tool in treatment and prevention of cell proliferative disorders |
| 10/04/2011 | US8029979 Method for determining the substrate specificity of an enzyme |
| 10/04/2011 | US8029787 Method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 10/04/2011 | US8029784 Method for the diagnosis and prognosis of malignant diseases |
| 10/04/2011 | US8029764 Isolating an mRNA sample from feces; detecting renal dipeptidase mRNA in the sample; comparing the amount the mRNA in the sample to amounts of renal dipeptidase mRNA in normal subjects, wherein an elevated level indicates colorectal cancer |
| 10/04/2011 | US8029733 Multicompartment heating apparatus comprising optical transmissive walls; cyclic DNA replication |
| 10/04/2011 | CA2474638C Microarray synthesis instrument and method |
| 10/04/2011 | CA2426959C Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation |
| 10/04/2011 | CA2402354C Rapid response glucose sensor |
| 10/04/2011 | CA2381777C Identification of genetic markers of biological age and metabolism |
| 10/04/2011 | CA2373160C Methods for monitoring eukaryotic cell integrity, growth and/or division |
| 10/04/2011 | CA2262819C Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein |
| 10/04/2011 | CA2245702C Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 10/04/2011 | CA2224075C Vectors for the diagnosis and treatment of solid tumors including melanoma |
| 09/29/2011 | WO2011120049A1 Methods for enhancing nucleic acid hybridization |
| 09/29/2011 | WO2011120048A2 Nanomotors and motion-based detection of biomolecular interactions |
| 09/29/2011 | WO2011120046A2 Methods and compositions for isolating polynucleotides |
| 09/29/2011 | WO2011120043A1 Methods and compositions for diagnosing and predicting risk of late-onset alzheimer's disease |
| 09/29/2011 | WO2011120020A1 Droplet transport system for detection |
| 09/29/2011 | WO2011120015A2 Method and system of particle-coupled phage epitope |
| 09/29/2011 | WO2011119994A2 Devices, systems, and methods for amplifying nucleic acids |
| 09/29/2011 | WO2011119986A2 Methods for culturing and analyzing cells |
| 09/29/2011 | WO2011119983A2 Biochemical oxygen demand automatic measurement device |
| 09/29/2011 | WO2011119980A1 Protein and gene biomarkers for rejection of organ transplants |
| 09/29/2011 | WO2011119934A2 Methods and materials for detecting colorectal neoplasm |
| 09/29/2011 | WO2011119906A1 HUMAN POLYOMAVIRUS 6 (HPyV6) AND HUMAN POLYOMAVIRUS 7 (HPyV7) |
| 09/29/2011 | WO2011119771A2 Methods and compositions for detecting protein modifications |
| 09/29/2011 | WO2011119739A1 Method and medium for accelerating target analyte growth in a test sample |
| 09/29/2011 | WO2011119724A2 Colorimetric and fluorescent proteins |
| 09/29/2011 | WO2011119637A1 Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomics |
| 09/29/2011 | WO2011119531A1 Mutations associated with cystic fibrosis |
| 09/29/2011 | WO2011119507A2 Method of altering the differentiative state of a cell and compositions thereof |
| 09/29/2011 | WO2011119492A2 Methods and compositions related to the measurement of material properties |
| 09/29/2011 | WO2011119235A1 Methods for conducting genetic analysis using protein polymorphism |
| 09/29/2011 | WO2011119057A1 A combinatorial library, a method for preparation of that combinatorial library, a method for sequence identification, a method for sequencing the elements of combinatorial libraries of oligonucleotides and/or oligonucleotide analogues, the use of a linker to generate combinatorial libraries and a sequence identification set |
| 09/29/2011 | WO2011118994A2 Nlk as a marker for diagnosis of liver cancer and as a therapeutic agent thereof |
| 09/29/2011 | WO2011118968A2 Single nucleotide polymorphism for diagnosis of recurrence of hepatocellular carcinoma |
| 09/29/2011 | WO2011118967A2 Single nucleotide polymorphism for the prognosis of hepatocellular carcinoma |
| 09/29/2011 | WO2011118765A1 Viable bacteria count measurement method and culture medium |
| 09/29/2011 | WO2011118764A1 Viable bacteria count measurement method and culture medium |
| 09/29/2011 | WO2011118655A1 Method for monitoring state of differentiation in stem cells |
| 09/29/2011 | WO2011118603A1 Method for detecting target base sequence using competitive primer |
| 09/29/2011 | WO2011118579A1 Fluorescent probe for plasma cell identification and isolation, and plasma cell identification or isolation method using the probe |
| 09/29/2011 | WO2011118549A1 Vertnin gene that controls number of vertebrae in pigs, and use of same |
| 09/29/2011 | WO2011118496A1 Primer and probe for detecting chlamydia trachomatis, and method for detecting chlamydia trachomatis using same |
| 09/29/2011 | WO2011118304A1 Screening method for therapeutic drug for heart disease |
| 09/29/2011 | WO2011118256A1 Collection unit |
| 09/29/2011 | WO2011118231A1 Rapid method for identifying drug-resistant gene using artificial chromosome of malaria parasite, and method for preparing recombinant malaria parasite |
| 09/29/2011 | WO2011117388A1 Method of molecular marker selection |
| 09/29/2011 | WO2011117366A2 Genes and genes combinations predictive of early response or non response of subjects suffering from inflammatory disease to cytokine targeting drugs (cytd) |
| 09/29/2011 | WO2011117267A1 Cladribine treatment of multiple sclerosis in patient groups defined by genotype |
| 09/29/2011 | WO2011117259A1 Methods for identifying inhibitors of the type iii secretion system |